Evidence map›Paper›PMID 32655658›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Anxiolytic Effect of Alcohol-Water Extracted Suanzaoren-Wuweizi Herb-Pair by Regulating ECS-BDNF-ERK Signaling Pathway Expression in Acute Restraint Stress Male Rats.

Cheng-Bo-Wen Zhao, Jie Liu, Jin-Li Shi, Shao-Nan Wang, Yong-Sheng Ding, Shuai He, Ming-Xuan Lin, Jing Luo, Yi-Nan Jiang, Li-Hua Bian and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Cheng-Bo-Wen Zhao *School of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.ORCID https://orcid.org/0000-0002-2428-9545
Jie Liu *Capital Institute of Pediatrics, No. 2 Yabao Road, Chaoyang District, Beijing, China.
Jin-Li ShiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.ORCID https://orcid.org/0000-0003-2797-1897
Shao-Nan WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Yong-Sheng DingSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Shuai HeSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Ming-Xuan LinSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Jing LuoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Yi-Nan JiangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Li-Hua BianSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Zi-Wei YaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Qiu-Yu LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Xiao-Mei WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Yangguang South Street, Fangshan District, Beijing 102488, China.
Jian-You GuoCAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, 4A Datun Road, Chaoyang District, Beijing 100101, China.ORCID https://orcid.org/0000-0002-2879-3386
Beijing University of Chinese Medicine · CNCapital Institute of Pediatrics · CNInstitute of Psychology, Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herb-pairs are the basic units of composition in Chinese herbal formulae, where the bridge linking Chinese medicine and prescription consists of two Chinese medicine herbs. The Suanzaoren-Wuweizi herb-pair (SWHP) is commonly used as a sedative or tranquilizer. SWHP has been demonstrated to exert an antianxiety effect in animal models of anxiety. However, little information about its mechanism is available and the effects of SWHP have not been investigated. This study examined the effects of SWHP on ameliorating anxiety-like behaviors by regulating endocannabinoids system (ECS)-brain-derived neurotrophic factor (BDNF)-extracellular regulated protein kinases (ERK) signaling pathway expression, induced by restraint stress (RS) procedures. The antianxiety effects of SWHP on RS rats were then examined through the open-field test (OF) and the elevated plus maze test (EPM). The concentration of BNDF, ERK1/2, p-ERK1/2, cAMP-response element binding protein (CREB), and p-CREB expression in the prefrontal cortex and hippocampus of the rats was then measured by western blot. The number of positive cells of CB1 and CB2 in the rats' hippocampus CA1 region was measured by immunohistochemistry. These results gave compelling evidence that SWHP could modify anxiety-like behaviors of RS rats through regulation of the ECS-BDNF-ERK signaling pathway. Our study demonstrated that SWHP improved anxiety-like behaviors in RS rat models by regulating the ECS-BDNF-ERK signaling pathway. The findings indicate that SWHP may have a therapeutic application in the RS model of anxiety disorder, which proposes a potential new direction for research into anxiety disorders regarding mechanisms and the development of novel antianxiety drugs.

Identifiers

PMID32655658
PMCPMC7317328
OpenAlexW3036123924

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.